As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

GLP-1 class of weight loss and diabetes drugs are linked to previously unrecognized health risks and benefits, according to a ...

Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions ...

Novo Nordisk (NVO) stock gains on promising Phase 1/2 data for the drugmaker's new weight loss drug amycretin. Read more here ...

A new study reveals that popular diabetes and weight loss medications like Ozempic and Wegovy may offer unexpected health ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

People lose weight via three primary methods: diet and exercise, weight loss surgery and GLP-1 weight loss drugs. The ...